Marvel to File for Orphan Drug Designation with The U.S. FDA for MB-204 as a Treatment for Rett Syndrome
Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc.
Why Down Syndrome campaigners are urging people to wear 'vibrant' odd socks
Staff at the Pioneering Care Centre in Newton Aycliffe are preparing to wear odd socks in support of Together 21, a program ...